dc.contributor.author |
Haddad J.J. |
dc.contributor.editor |
|
dc.date |
2005 |
dc.date.accessioned |
2017-10-03T15:43:35Z |
dc.date.available |
2017-10-03T15:43:35Z |
dc.date.issued |
2005 |
dc.identifier |
10.1016/j.bbrc.2004.11.166 |
dc.identifier.isbn |
|
dc.identifier.issn |
|
dc.identifier.uri |
http://hdl.handle.net/10938/12513 |
dc.description.abstract |
Understanding the biophysics of fluid dynamics within the context of transcriptional regulation, mediated by nuclear factor (NF)-κB, is crucial to developing a consensus on the molecular basis of fluid mechanics and imbalance. Amiloride, an antikaliuretic-diuretic agent, has recently entered the realm of NF-κB as a key player in regulating the molecular association of fluid dynamics with inflammation and oxidative stress. With the identification of flanking regions encoding the amiloride-sensitive channels that are NF-κB-responsive, a new theme emerges which underlies the significance of this association. What is the role of NF-κB in regulating fluid mechanics-is it a physiologic or immunologic function? Conversely, amiloride is purported as a major regulator of this transcriptional pathway. It is the mainstream of this survey, therefore, to outline current advances on the biophysics and nature of the interaction existing between amiloride, amiloride-sensitive channels, and NF-κB, while searching for potential molecular mechanisms. © 2004 Published by Elsevier Inc. |
dc.format.extent |
|
dc.format.extent |
Pages: (373-381) |
dc.language |
English |
dc.publisher |
SAN DIEGO |
dc.relation.ispartof |
Publication Name: Biochemical and Biophysical Research Communications; Publication Year: 2005; Volume: 327; no. 2; Pages: (373-381); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Amiloride and the regulation of NF-κB: An unsung crosstalk and missing link between fluid dynamics and oxidative stress-related inflammation - Controversy or pseudo-controversy? |
dc.type |
Review |
dc.contributor.affiliation |
Haddad, J.J., Department of Biology, Faculty of Arts and Sciences, Amer. Univ. Beirut, Beirut, Lebanon, United States, Depts. of Biol. and Biomed. Sciences, Faculty of Arts and Sciences, Lebanese Intl. Univ., Beirut, L., Lebanon |
dc.contributor.authorAddress |
Department of Biology, Faculty of Arts and Sciences, Amer. Univ. Beirut, Beirut, LebanonUnited States; email: johnjhaddad@yahoo.co.uk |
dc.contributor.authorCorporate |
University: American University of Beirut; Faculty: Faculty of Arts and Sciences; Department: Biology; |
dc.contributor.authorDepartment |
Biology |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
johnjhaddad@yahoo.co.uk |
dc.contributor.faculty |
Faculty of Arts and Sciences |
dc.contributor.authorInitials |
Haddad, JJ |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Haddad, JJ (reprint author), Amer Univ Beirut, Fac Arts and Sci, Dept Biol, Beirut, Lebanon. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut |
dc.description.cited |
Baines DL, 2002, BIOCHEM J, V364, P537, DOI 10.1042-BJ20011651; Baines DL, 2001, J PHYSIOL-LONDON, V532, P105, DOI 10.1111-j.1469-7793.2001.0105g.x; Barchowsky A, 1998, TOXICOL APPL PHARM, V152, P388, DOI 10.1006-taap.1998.8462; Bellocq A, 1998, J BIOL CHEM, V273, P5086, DOI 10.1074-jbc.273.9.5086; Coffey MJ, 2004, EXP LUNG RES, V30, P615, DOI 10.1080-01902140490476391; COSTELLOBOERRIGTER, 2003, MED CLIN N AM, V87, P475; Donadelli R, 2003, J AM SOC NEPHROL, V14, P2436, DOI 10.1097-01.ASN.0000089564.55411.7F; Drumm K, 2001, EUR J MED RES, V6, P422; Garty H, 1997, PHYSIOL REV, V77, P359; GRANTHAM JJ, 1989, J LAB CLIN MED, V114, P129; Haddad JJ, 2002, AM J RESP CELL MOL, V26, P114; Jung SW, 2004, INT J ONCOL, V25, P1081; Komiya T, 2004, INT J MOL MED, V13, P133; Morgan JD, 2003, BRIT J CLIN PHARMACO, V55, P317, DOI 10.1046-j.1365-2125.2003.01784.x; Nemeth ZH, 2002, AM J PHYSIOL-GASTR L, V283, pG122, DOI 10.1152-ajpgi.00015.2002; Nemeth ZH, 2002, AM J PHYSIOL-CELL PH, V283, pC396, DOI 10.1152-ajpcell.00491.2001; Otulakowski G, 1999, AM J RESP CELL MOL, V20, P1028; Park KC, 2004, BIOCHEM BIOPH RES CO, V323, P1055, DOI 10.1016-j.bbrc.2004.08.204; Pedersen SF, 2004, J EXP ZOOL PART A, V301A, P569, DOI 10.1002-jez.a.47; Pitkanen O, 1996, AM J PHYSIOL-LUNG C, V270, pL1060; PITKANEN OM, 1995, AM J PHYSIOL-LUNG C, V268, pL762; Rafii B, 1998, AM J PHYSIOL-LUNG C, V275, pL764; Rossier B C, 1994, Curr Opin Nephrol Hypertens, V3, P487, DOI 10.1097-00041552-199409000-00003; Suzuki T, 2001, AM J PHYSIOL-LUNG C, V280, pL1115; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146-annurev.physiol.59.1.659; TING CC, 1995, IMMUNOPHARMACOLOGY, V30, P119, DOI 10.1016-0162-3109(95)00013-J; Treadwell MD, 1996, TOXICOL APPL PHARM, V139, P62, DOI 10.1006-taap.1996.0143; Wazny LD, 2000, ANN PHARMACOTHER, V34, P94 |
dc.description.citedCount |
10 |
dc.description.citedTotWOSCount |
11 |
dc.description.citedWOSCount |
10 |
dc.format.extentCount |
9 |
dc.identifier.articleNo |
|
dc.identifier.coden |
BBRCA |
dc.identifier.pubmedID |
15629126 |
dc.identifier.scopusID |
11144300132 |
dc.identifier.url |
|
dc.publisher.address |
525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Biochem. Biophys. Res. Commun. |
dc.relation.ispartOfIssue |
2 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Biochemical and Biophysical Research Communications |
dc.relation.ispartofPubTitleAbbr |
Biochem. Biophys. Res. Commun. |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
327 |
dc.source.ID |
WOS:000226364000001 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
Amiloride |
dc.subject.otherAuthKeyword |
Anti-diuretic |
dc.subject.otherAuthKeyword |
Cytokine |
dc.subject.otherAuthKeyword |
ENaC |
dc.subject.otherAuthKeyword |
Fluid |
dc.subject.otherAuthKeyword |
NF-κB |
dc.subject.otherAuthKeyword |
Transcription |
dc.subject.otherChemCAS |
(3 methylsulfonyl 4 piperidinobenzoyl)guanidine methanesulfonate, 141923-47-9 |
dc.subject.otherChemCAS |
21 [4 [2,6 bis(1 pyrrolidinyl) 4 pyrimidinyl] 1 piperazinyl]pregna 1,4,9(11) triene 3,20 dione, 111668-89-4 |
dc.subject.otherChemCAS |
amiloride, 2016-88-8, 2609-46-3 |
dc.subject.otherChemCAS |
bafilomycin A1, 88899-55-2 |
dc.subject.otherChemCAS |
cimetidine, 51481-61-9, 70059-30-2 |
dc.subject.otherChemCAS |
clonidine, 4205-90-7, 4205-91-8, 57066-25-8 |
dc.subject.otherChemCAS |
harmaline, 304-21-2 |
dc.subject.otherChemCAS |
ibuprofen, 15687-27-1, 79261-49-7 |
dc.subject.otherChemCAS |
mitogen activated protein kinase, 142243-02-5 |
dc.subject.otherChemCAS |
trolox C, 56305-04-5 |
dc.subject.otherChemCAS |
urokinase, 139639-24-0 |
dc.subject.otherChemCAS |
Amiloride, 2609-46-3 |
dc.subject.otherChemCAS |
Diuretics |
dc.subject.otherChemCAS |
NF-kappa B |
dc.subject.otherIndex |
(3 methylsulfonyl 4 piperidinobenzoyl)guanidine methanesulfonate |
dc.subject.otherIndex |
21 [4 [2,6 bis(1 pyrrolidinyl) 4 pyrimidinyl] 1 piperazinyl]pregna 1,4,9(11) triene 3,20 dione |
dc.subject.otherIndex |
amiloride |
dc.subject.otherIndex |
bafilomycin A1 |
dc.subject.otherIndex |
cimetidine |
dc.subject.otherIndex |
clonidine |
dc.subject.otherIndex |
cytokine |
dc.subject.otherIndex |
diuretic agent |
dc.subject.otherIndex |
harmaline |
dc.subject.otherIndex |
ibuprofen |
dc.subject.otherIndex |
immunoglobulin enhancer binding protein |
dc.subject.otherIndex |
ion channel |
dc.subject.otherIndex |
mitogen activated protein kinase |
dc.subject.otherIndex |
trolox C |
dc.subject.otherIndex |
urokinase |
dc.subject.otherIndex |
acidity |
dc.subject.otherIndex |
biosynthesis |
dc.subject.otherIndex |
concentration response |
dc.subject.otherIndex |
cytokine production |
dc.subject.otherIndex |
drug activity |
dc.subject.otherIndex |
drug effect |
dc.subject.otherIndex |
drug mechanism |
dc.subject.otherIndex |
drug specificity |
dc.subject.otherIndex |
dynamics |
dc.subject.otherIndex |
enzyme activity |
dc.subject.otherIndex |
enzyme regulation |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
immune system |
dc.subject.otherIndex |
immunoregulation |
dc.subject.otherIndex |
inflammation |
dc.subject.otherIndex |
inhibition kinetics |
dc.subject.otherIndex |
kidney interstitium |
dc.subject.otherIndex |
liquid |
dc.subject.otherIndex |
microenvironment |
dc.subject.otherIndex |
molecular dynamics |
dc.subject.otherIndex |
molecular interaction |
dc.subject.otherIndex |
molecular mechanics |
dc.subject.otherIndex |
nonhuman |
dc.subject.otherIndex |
oxidative stress |
dc.subject.otherIndex |
pH |
dc.subject.otherIndex |
physics |
dc.subject.otherIndex |
priority journal |
dc.subject.otherIndex |
protein analysis |
dc.subject.otherIndex |
protein function |
dc.subject.otherIndex |
regulatory mechanism |
dc.subject.otherIndex |
review |
dc.subject.otherIndex |
Rhinovirus |
dc.subject.otherIndex |
transcription regulation |
dc.subject.otherIndex |
Amiloride |
dc.subject.otherIndex |
Animals |
dc.subject.otherIndex |
Diuretics |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Inflammation |
dc.subject.otherIndex |
NF-kappa B |
dc.subject.otherIndex |
Oxidative Stress |
dc.subject.otherKeywordPlus |
NITRIC-OXIDE SYNTHASE |
dc.subject.otherKeywordPlus |
ENDOTHELIAL-CELLS |
dc.subject.otherKeywordPlus |
NA+-H+ EXCHANGER |
dc.subject.otherKeywordPlus |
EPITHELIAL-CELLS |
dc.subject.otherKeywordPlus |
SODIUM-CHANNEL |
dc.subject.otherKeywordPlus |
ACTIVATION |
dc.subject.otherKeywordPlus |
LIPOPOLYSACCHARIDE |
dc.subject.otherKeywordPlus |
MACROPHAGES |
dc.subject.otherKeywordPlus |
INVOLVEMENT |
dc.subject.otherKeywordPlus |
INHIBITION |
dc.subject.otherWOS |
Biochemistry and Molecular Biology |
dc.subject.otherWOS |
Biophysics |